186 related articles for article (PubMed ID: 17671204)
1. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.
Gómez-Varela D; Zwick-Wallasch E; Knötgen H; Sánchez A; Hettmann T; Ossipov D; Weseloh R; Contreras-Jurado C; Rothe M; Stühmer W; Pardo LA
Cancer Res; 2007 Aug; 67(15):7343-9. PubMed ID: 17671204
[TBL] [Abstract][Full Text] [Related]
2. Eag1: an emerging oncological target.
Pardo LA; Stühmer W
Cancer Res; 2008 Mar; 68(6):1611-3. PubMed ID: 18339837
[TBL] [Abstract][Full Text] [Related]
3. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
[TBL] [Abstract][Full Text] [Related]
5. Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B.
Sahoo N; Tröger J; Heinemann SH; Schönherr R
FEBS Lett; 2010 Sep; 584(18):3896-900. PubMed ID: 20708613
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Eag1 potassium channels in clinical tumours.
Hemmerlein B; Weseloh RM; Mello de Queiroz F; Knötgen H; Sánchez A; Rubio ME; Martin S; Schliephacke T; Jenke M; Heinz-Joachim-Radzun ; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():41. PubMed ID: 17022810
[TBL] [Abstract][Full Text] [Related]
7. Ether à go-go potassium channel expression in soft tissue sarcoma patients.
Mello de Queiroz F; Suarez-Kurtz G; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():42. PubMed ID: 17022811
[TBL] [Abstract][Full Text] [Related]
8. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo.
Zhao J; Wei XL; Jia YS; Zheng JQ
Eur J Pharmacol; 2008 Jan; 579(1-3):50-7. PubMed ID: 17976575
[TBL] [Abstract][Full Text] [Related]
9. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
10. Refining insights into high-affinity drug binding to the human ether-à-go-go-related gene potassium channel.
Hancox JC; James AF
Mol Pharmacol; 2008 Jun; 73(6):1592-5. PubMed ID: 18381562
[TBL] [Abstract][Full Text] [Related]
11. Role of voltage-gated potassium channels in cancer.
Pardo LA; Contreras-Jurado C; Zientkowska M; Alves F; Stühmer W
J Membr Biol; 2005 Jun; 205(3):115-24. PubMed ID: 16362499
[TBL] [Abstract][Full Text] [Related]
12. Tetrandrine, a novel inhibitor of ether-à-go-go-1 (Eag1), targeted to cervical cancer development.
Wang X; Chen Y; Li J; Guo S; Lin X; Zhang H; Zhan Y; An H
J Cell Physiol; 2019 May; 234(5):7161-7173. PubMed ID: 30362536
[TBL] [Abstract][Full Text] [Related]
13. Combining cluster analysis, feature selection and multiple support vector machine models for the identification of human ether-a-go-go related gene channel blocking compounds.
Nisius B; Göller AH; Bajorath J
Chem Biol Drug Des; 2009 Jan; 73(1):17-25. PubMed ID: 19152631
[TBL] [Abstract][Full Text] [Related]
14. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of potassium channel ether à go-go in human osteosarcoma.
Wu J; Wu X; Lian K; Lin B; Guo L; Ding Z
Neoplasma; 2012; 59(2):207-15. PubMed ID: 22248279
[TBL] [Abstract][Full Text] [Related]
16. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
17. 3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity.
Hoyt SB; London C; Wyvratt MJ; Fisher MH; Cashen DE; Felix JP; Garcia ML; Li X; Lyons KA; Euan MacIntyre D; Martin WJ; Priest BT; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2008 Mar; 18(6):1963-6. PubMed ID: 18289851
[TBL] [Abstract][Full Text] [Related]
18. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
20. Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain.
Martin S; Lino de Oliveira C; Mello de Queiroz F; Pardo LA; Stühmer W; Del Bel E
Neuroscience; 2008 Aug; 155(3):833-44. PubMed ID: 18650019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
